Skip to content

Harm-reduction information only — not medical advice. In crisis or experiencing adverse effects, contact a healthcare professional or your local emergency services immediately.

AnabolicPlotter logo AnabolicPlotter
Search (no-JS fallback)

Articles

Source-cited research guides on anabolic pharmacokinetics, cycle design, PCT, bloodwork, and harm reduction. Each article links to the relevant compound pages and calculators. Start with PCT fundamentals or reading bloodwork, or browse by topic below.

Aug 16, 2026 · 6 min read

Anavar vs Winstrol: Oral Cutting Steroids Compared

Anavar vs Winstrol compared with real PK data: half-lives, liver strain, HDL impact, joint dryness, cost, counterfeits, and harm-reduction context.

Jul 27, 2026 · 9 min read

On-Cycle Ancillaries: AIs, SERMs, and Cabergoline

On-cycle ancillaries explained: aromatase inhibitors (Arimidex, Aromasin), SERMs (Nolvadex, Clomid), and cabergoline, when each is used, and harm reduction.

Jul 27, 2026 · 8 min read

Arimidex vs Aromasin: AI Comparison for E2 Control

Arimidex (anastrozole) vs Aromasin (exemestane): half-lives, reversible vs suicidal mechanism, over-suppression risk, and harm reduction for E2 control.

Jul 27, 2026 · 8 min read

Cabergoline: Prolactin Management on Cycle

Cabergoline pharmacokinetics, 86-hour half-life, prolactin management on 19-nors, cardiac valve risk, impulse control effects, and harm reduction.

Jul 27, 2026 · 8 min read

Cycle Length: Short vs Long Ester Timing

How ester half-life drives cycle length: steady state, PCT timing, washout, and why short and long esters need different cycle structures.

Jul 27, 2026 · 9 min read

First Testosterone Cycle: A Harm-Reduction Primer

First testosterone cycle harm-reduction primer: why a testosterone-only base, ester choice, dose, injection frequency, bloodwork, AI use, and PCT planning.

Jul 21, 2026 · 8 min read

Dihydroboldenone (DHB): What the Research Shows

DHB (1-testosterone) is a potent non-aromatizing anabolic with limited human data. Half-life ~9 days, injection-site pain, and how it compares to tren and primo.

Jul 20, 2026 · 8 min read

Anadrol (Oxymetholone): Strength and Mass

Anadrol (oxymetholone) pharmacokinetics, 8-hour half-life, severe hepatotoxicity, erythropoiesis, water retention, detection, and harm reduction.

Jul 20, 2026 · 7 min read

AndroGel (Testosterone Gel): Benefits, Risks, and What to Know

AndroGel benefits for men with low T, the off-label women debate, and the secondary-transfer side effects that dominate harm reduction. Research-based guide.

Jul 20, 2026 · 5 min read

Cardarine (GW-501516): Benefits, Risks, and What the Research Shows

The real cardarine benefits for cardio and fat loss come from animal studies, and human trials ended after cancer signals. Here is what the research shows.

Jul 20, 2026 · 8 min read

Equipoise (Boldenone): Lean Mass Research Guide

Equipoise (boldenone undecylenate) pharmacokinetics, 14-day half-life, erythropoiesis, detection window, lipids, and harm reduction for research.

Jul 20, 2026 · 8 min read

Masteron: Propionate vs Enanthate for Cutting

Masteron (drostanolone) propionate vs enanthate: half-lives, injection frequency, anti-estrogenic DHT action, lipids, detection, and harm reduction.

Jul 20, 2026 · 8 min read

Primobolan (Methenolone): The Mildest Injectable

Primobolan (methenolone) oral vs injectable: half-lives, mild side-effect profile, DHT-derivative pharmacokinetics, detection, and harm reduction.

Jul 20, 2026 · 9 min read

SARMs Complete Guide: Ostarine, Ligandrol, RAD-140

Ostarine, Ligandrol, and RAD-140 compared: half-lives, suppression, hepatotoxicity, detection windows, source quality risks, and harm reduction.

Jul 13, 2026 · 8 min read

Anavar (Oxandrolone): Complete Research Guide

Anavar (oxandrolone) pharmacokinetics, half-life, dosing frequency, lipid effects, hepatotoxicity, detection, and harm reduction for research contexts.

Jul 13, 2026 · 8 min read

Dianabol (Methandrostenolone): The Original Mass Builder

Dianabol (methandrostenolone) pharmacokinetics, half-life, aromatization, hepatotoxicity, dosing frequency, detection, and harm reduction.

Jul 13, 2026 · 9 min read

Nandrolone: Deca vs NPP (Phenylpropionate)

Nandrolone decanoate (Deca) vs phenylpropionate (NPP): half-lives, injection frequency, detection windows, prolactin management, and harm reduction.

Jul 13, 2026 · 9 min read

Trenbolone: Acetate vs Enanthate vs Hexahydrobenzylcarbonate

Trenbolone ester comparison: half-lives, injection frequency, side effects, and harm reduction for acetate, enanthate, and hexahydrobenzylcarbonate (Parabolan).

Jul 13, 2026 · 8 min read

Winstrol: Oral vs Injectable (Stanozolol)

Winstrol (stanozolol) oral vs injectable: half-lives, hepatotoxicity, joint pain, SHBG lowering, detection windows, and harm reduction.

Jun 21, 2026 · 5 min read

How Long Does Testosterone Stay Detectable?

Testosterone esters and their anti-doping detection windows, why metabolites, not the parent hormone, determine how long a test stays positive.

Mar 31, 2025 · 7 min read

Testosterone Enanthate vs Cypionate: What's the Difference?

A head-to-head comparison of the two most common TRT esters, half-life, PK curves, injection frequency, and whether the difference matters in practice.

Feb 28, 2025 · 10 min read

Testosterone Cypionate: A Complete Research Guide

Ester mechanics, pharmacokinetics, dosing frequency, aromatization, and harm reduction for testosterone cypionate, the most common TRT ester in the US.

Feb 19, 2025 · 9 min read

Tapering, Cruising, and Coming Off

The three end-of-cycle strategies (PCT recovery, cruise, taper), pros and cons of each, when each makes sense, and how to time them with clearance math.

Feb 14, 2025 · 9 min read

Compound Interactions to Watch

Pharmacokinetic and pharmacodynamic interactions that matter when stacking anabolics, from trenbolone and thyroid to oral stacking and hepatic load.

Feb 9, 2025 · 8 min read

Injection Frequency and Steady State

How injection frequency affects peak-to-trough ratio, why twice-weekly beats weekly for test esters, and how to visualize frequency in the plotter.

Feb 4, 2025 · 10 min read

Reading Bloodwork: Testosterone Reference Ranges

Key markers (total T, free T, E2, hematocrit, lipids, liver enzymes, PSA), what each tells you, reference ranges, and when to draw labs at trough.

Jan 31, 2025 · 9 min read

SARMs vs. AAS: Harm Reduction Comparison

How SARMs and anabolic-androgenic steroids differ in mechanism, side effects, suppression, detection, and harm profile. Not the safer alternative marketing claims.

Jan 24, 2025 · 10 min read

PCT Fundamentals

How the HPTA is suppressed, when to start PCT by ester, SERM options like nolvadex and clomid, and why post-PCT bloodwork matters.

Jan 19, 2025 · 9 min read

Aromatase Inhibitor Timing

When to start an AI on cycle, symptoms of high vs low estradiol, bloodwork timing, and arimidex vs aromasin differences for harm reduction.

Jan 14, 2025 · 10 min read

Testosterone Ester Comparison

How ester chemistry controls testosterone release, a half-life table for all major esters, and how to choose the right ester using the comparison tool.